| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2019/05/04 | 05:36 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(b) (15-12b) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/27 | 05:53 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/25 | 00:58 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/25 | 00:56 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/25 | 00:55 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/25 | 00:53 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/25 | 00:52 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/25 | 00:50 | Edgar (US Regulatory) | Post-effective Amendment to an S-8 Filing (s-8 Pos) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/24 | 05:19 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/24 | 05:18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/24 | 05:18 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/24 | 05:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/24 | 05:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/24 | 05:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/24 | 05:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/24 | 05:17 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/24 | 05:16 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/23 | 22:28 | GlobeNewswire Inc. | Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Completion of the Merger with OncoMed Pharmaceuticals, ... | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/23 | 22:01 | Edgar (US Regulatory) | Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ... | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/18 | 15:00 | GlobeNewswire Inc. | Mereo BioPharma Group plc ("Mereo" or the "Company" or the "Group") Merger Update: Acquisition of OncoMed Pharmaceuticals, In... | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/18 | 04:27 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/04/18 | 04:25 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/03/21 | 06:06 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (defm14a) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/03/16 | 05:42 | Edgar (US Regulatory) | Statement of Beneficial Ownership (sc 13d) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/03/15 | 21:35 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/03/15 | 20:20 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/03/15 | 20:20 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/03/15 | 20:00 | GlobeNewswire Inc. | OncoMed Pharmaceuticals Declares Special Dividend of Contingent Value Rights | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/03/12 | 22:28 | Edgar (US Regulatory) | Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |
| 2019/03/08 | 06:41 | Edgar (US Regulatory) | Annual Report (10-k) | NASDAQ:OMED | Oncomed Pharmaceuticals, Inc. |